JP2024506954A5 - - Google Patents
Info
- Publication number
- JP2024506954A5 JP2024506954A5 JP2023549900A JP2023549900A JP2024506954A5 JP 2024506954 A5 JP2024506954 A5 JP 2024506954A5 JP 2023549900 A JP2023549900 A JP 2023549900A JP 2023549900 A JP2023549900 A JP 2023549900A JP 2024506954 A5 JP2024506954 A5 JP 2024506954A5
- Authority
- JP
- Japan
- Prior art keywords
- homing
- tumor
- vaccine according
- strain
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150681P | 2021-02-18 | 2021-02-18 | |
| US63/150,681 | 2021-02-18 | ||
| PCT/IL2022/050191 WO2022175951A1 (en) | 2021-02-18 | 2022-02-17 | Genetically modified bacteria for generating vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506954A JP2024506954A (ja) | 2024-02-15 |
| JP2024506954A5 true JP2024506954A5 (https=) | 2025-02-25 |
Family
ID=80623424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549900A Pending JP2024506954A (ja) | 2021-02-18 | 2022-02-17 | ワクチン作製用の遺伝子改変細菌 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240009286A1 (https=) |
| EP (1) | EP4294429A1 (https=) |
| JP (1) | JP2024506954A (https=) |
| CA (1) | CA3208536A1 (https=) |
| IL (1) | IL305314A (https=) |
| WO (1) | WO2022175951A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL295726A (en) | 2022-08-17 | 2024-03-01 | Yeda res & development co ltd | Genetically modified bacteria for generating vaccines |
| WO2024038462A1 (en) | 2022-08-17 | 2024-02-22 | Yeda Research And Development Co. Ltd. | Novel bacteria-based delivery system for tace (adam17) selective biological inhibitor |
| WO2025177207A1 (en) * | 2024-02-21 | 2025-08-28 | Baccine Ltd | Inducible immunomodulating tumor-homing bacteria |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| NL154599B (nl) | 1970-12-28 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen, alsmede testverpakking. |
| US3901654A (en) | 1971-06-21 | 1975-08-26 | Biological Developments | Receptor assays of biologically active compounds employing biologically specific receptors |
| US3853987A (en) | 1971-09-01 | 1974-12-10 | W Dreyer | Immunological reagent and radioimmuno assay |
| US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
| NL171930C (nl) | 1972-05-11 | 1983-06-01 | Akzo Nv | Werkwijze voor het aantonen en bepalen van haptenen, alsmede testverpakkingen. |
| US3850578A (en) | 1973-03-12 | 1974-11-26 | H Mcconnell | Process for assaying for biologically active molecules |
| US3935074A (en) | 1973-12-17 | 1976-01-27 | Syva Company | Antibody steric hindrance immunoassay with two antibodies |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4034074A (en) | 1974-09-19 | 1977-07-05 | The Board Of Trustees Of Leland Stanford Junior University | Universal reagent 2-site immunoradiometric assay using labelled anti (IgG) |
| US3984533A (en) | 1975-11-13 | 1976-10-05 | General Electric Company | Electrophoretic method of detecting antigen-antibody reaction |
| US4098876A (en) | 1976-10-26 | 1978-07-04 | Corning Glass Works | Reverse sandwich immunoassay |
| US4879219A (en) | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| US5011771A (en) | 1984-04-12 | 1991-04-30 | The General Hospital Corporation | Multiepitopic immunometric assay |
| US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
| US5272057A (en) | 1988-10-14 | 1993-12-21 | Georgetown University | Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase |
| US5192659A (en) | 1989-08-25 | 1993-03-09 | Genetype Ag | Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| US5281521A (en) | 1992-07-20 | 1994-01-25 | The Trustees Of The University Of Pennsylvania | Modified avidin-biotin technique |
| EP1943344A2 (en) * | 2005-10-04 | 2008-07-16 | The Ludwig Institute for Cancer Research | Methods for stimulating an immune response using bacterial antigen delivery system |
| KR100985914B1 (ko) * | 2006-12-13 | 2010-10-08 | 주식회사 바이오리더스 | 간암 특이 항원인 알파페토단백질의 표면발현벡터 및 이에의해 형질전환된 미생물 |
| EP2604682A1 (en) * | 2011-12-12 | 2013-06-19 | Universite Joseph Fourier - Grenoble 1 | Attenuated and adapted strain of pseudomonas for delivering antigens |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| EP3570857A1 (en) | 2017-01-18 | 2019-11-27 | Evelo Biosciences, Inc. | Methods of treating cancer |
| EP3406731A1 (en) | 2017-05-22 | 2018-11-28 | Commissariat à l'Energie Atomique et aux Energies Alternatives | Metabolic labeling of bacterial teichoic acids cell wall |
| JP7598315B2 (ja) * | 2018-09-05 | 2024-12-11 | エンエーセー オンコイミュニティ アクスイェ セルスカプ | 併用療法用ｄｎａワクチンを標的とするネオアンチゲン |
-
2022
- 2022-02-17 WO PCT/IL2022/050191 patent/WO2022175951A1/en not_active Ceased
- 2022-02-17 CA CA3208536A patent/CA3208536A1/en active Pending
- 2022-02-17 JP JP2023549900A patent/JP2024506954A/ja active Pending
- 2022-02-17 IL IL305314A patent/IL305314A/en unknown
- 2022-02-17 EP EP22707258.4A patent/EP4294429A1/en active Pending
-
2023
- 2023-08-17 US US18/234,902 patent/US20240009286A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506954A5 (https=) | ||
| Shuwen et al. | Intestinal phages interact with bacteria and are involved in human diseases | |
| JP2019108378A5 (https=) | ||
| Karam et al. | Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli | |
| Maroof et al. | Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model | |
| Carson et al. | Non-antibiotic therapies for infectious diseases | |
| WO2009019612A3 (en) | Lentiviral gene transfer vectors and their medicinal applications | |
| Kumari et al. | Efficacy of bacteriophage treatment in murine burn wound infection induced by klebsiella pneumoniae. | |
| JP2019163267A5 (https=) | ||
| JP2019517828A5 (https=) | ||
| CY1118006T1 (el) | Χρηση γαλακτοβακιλλων για την αγωγη ιικων λοιμωξεων | |
| JP2021523895A5 (https=) | ||
| DE60227157D1 (de) | Impstoffe zur transkutanen immunisierung gegen reisediarrhö | |
| JP2016539946A5 (https=) | ||
| Feyisetan et al. | Probiotics, dendritic cells and bladder cancer | |
| EP1305042B1 (en) | Compositions comprising non-typable Haemophilus influenzae (NTHI) and probiotic bacteria for the treatment of mucosal infections caused by NTHI | |
| WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
| Vargová et al. | Probiotic bacteria can modulate murine macrophage’s superoxide production in Trichinella spiralis infection | |
| WO2023004415A3 (en) | Sars-cov-2 vaccine using bacterial spores expressing antigenic fragments | |
| Silva et al. | and Other Infectious Diseases: Lactobacillus spp. and Other Potential Bacterial Species | |
| Kuhl et al. | Diseases caused by phages | |
| WO2020201833A8 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
| JP2021502391A5 (https=) | ||
| JP2005503126A5 (https=) | ||
| Palaniappan et al. | Therapeutic efficacy of bacteriophages |